| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WGS | Class A Common Stock | Sale | $1,317,505 | -39,824 | -1.4% | $33.08 | 2,746,972 | 15 Aug 2024 | Direct | F1 |
| transaction | WGS | Class A Common Stock | Sale | $1,714,850 | -50,000 | -1.8% | $34.30 | 2,696,972 | 16 Aug 2024 | Direct | F2 |
| transaction | WGS | Class A Common Stock | Sale | $1,724,520 | -50,000 | -1.9% | $34.49 | 2,646,972 | 19 Aug 2024 | Direct | F3 |
OPKO HEALTH, INC. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
| Id | Content |
|---|---|
| F1 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $34.26, inclusive. The reporting person undertakes to provide to GeneDx Holding Corp. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. |
| F2 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.84 to $34.86, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4. |
| F3 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $35.53, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (3) to this Form 4. |